LAMF
LAMF

Coronavirus Update | Active cases in India dip to 1,940

The death toll stands at 5,30,730 with one death reconciled by Kerala and one reported by Uttar Pradesh in the last 24 hours, according to the data updated at 8 am.
January 21, 2023 / 10:28 IST
(Image: AP)

India saw a single-day rise of 131 new coronavirus infections while active cases declined to 1,940, according to Union Health Ministry data updated on Saturday.

The total number of Covid cases was recorded at 4.46 crore (4,46,81,781).

The death toll stands at 5,30,730 with one death reconciled by Kerala and one reported by Uttar Pradesh in the last 24 hours, according to the data updated at 8 am.

Both the daily and weekly positivity were recorded at 0.08 per cent.

The active cases now comprise 0.01 per cent of the total infections while the national COVID-19 recovery rate has risen to 98.81 per cent, according to the Health ministry's website.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

A decrease of six cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

The number of people who have recuperated from the disease surged to 4,41,49,111 while the case fatality rate was recorded at 1.19 per cent.

According to the ministry website, 220.24 crore doses of Covid vaccine have been administered under the nationwide COVID-19 vaccination drive so far.

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It crossed 60 lakh cases on September 28, 70 lakh on October 11, 80 lakh on October 29, 90 lakh on November 20 and the one-crore mark on December 19.

The grim milestone of two crore cases was passed on May 4 and three crore on June 23, 2021. The four-crore cases mark was hit on January 25, 2022.

PTI

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347